The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
- Autores
- Yang, Pablo; Luna, José Domingo; Alcoba, Emilio; Sein, Aylén; Gramajo, Ana Laura; Juárez, Claudio P.; Beltramo, Dante Miguel; Soria, Néstor Walter
- Año de publicación
- 2018
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Purpose: Diabetic retinopathy (DR) is one of the chronic retinal disorders linked to diabetes and remains the leading cause of blindness in working-age people. Many studies have demonstrated the existence of associations between type 2 diabetes mellitus (T2DM) and variants in the cyclin-dependent kinase 5 regulatory subunit?associated protein 1-like 1 (CDKAL1) gene. Here, weperformed a case-control study in the CDKAL1 gene (rs4712527 polymorphism) to investigate the potential association between this single-nucleotide polymorphism (SNP) and DR risk. Methods: Two hundred thirty-one patients with T2DM (126 patients with proliferative diabetic retinopathy [PDR] and 105 patients without diabetic retinopathy [WDR]), who assisted at the CentroPrivado de Ojos Romagosa, Fundacio´n VER, were studied. An independent cohort of 98 patients (56 with PDR and 42 with WDR) from the Hospital Nacional de Clı´nicas was taken for replication. A complete ophthalmological examination included an externalexamination of the eye and adnexa, pupil responsiveness, and slit-lamp biomicroscopic examination. Genotyping of rs4712527 was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The odds ratio (OR) and 95% CI were calculated by unconditional logistic regression adjusted for diabetes duration, body mass index, insulin therapy,HbA1c, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure. Results: Analysis from the rs4712527 SNP in the Centro Privado de Ojos Romagosa, Fundacio´n VER, cohort was found to be associated with decreased risk of PDR both before and after adjustment, under the codominant (adjustedOR ¼ 0.16 [95% CI, 0.06-0.44]; P ¼ 4e-04), dominant (adjusted OR ¼ 0.17 [95% CI, 0.07-0.43]; P ¼ 1e-04), overdominant (adjusted OR ¼ 0.20 [95% CI, 0.08-0.52]; P ¼ 5e-04), and log-additive (adjusted OR ¼ 0.28 [95% CI, 0.13-0.59]; P ¼ 4e-04)models. In the combined analysis including both cohorts, the rs4712527 was nominally involved as a protective factor in the development of DR. Conclusions: Our findings suggest that the rs4712527 in the CDKAL1 gene might be involved in the protection to develop PDR in T2DM.
Fil: Yang, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina
Fil: Luna, José Domingo. Fundaciòn Ver; Argentina
Fil: Alcoba, Emilio. Fundaciòn Ver; Argentina
Fil: Sein, Aylén. Fundaciòn Ver; Argentina
Fil: Gramajo, Ana Laura. Fundaciòn Ver; Argentina
Fil: Juárez, Claudio P.. Fundaciòn Ver; Argentina
Fil: Beltramo, Dante Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Provincia de Córdoba. Ministerio de Ciencia y Técnica. Centro de Excelencia en Productos y Procesos de Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina
Fil: Soria, Néstor Walter. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina - Materia
-
CDKAL1 GENE
POLYMORPHISM
RS4712527
DIABETIC RETINOPATHY
TYPE 2 DIABETES - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/164341
Ver los metadatos del registro completo
| id |
CONICETDig_3fc1c2832e6d233fdc21db020bfd4a71 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/164341 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetesYang, PabloLuna, José DomingoAlcoba, EmilioSein, AylénGramajo, Ana LauraJuárez, Claudio P.Beltramo, Dante MiguelSoria, Néstor WalterCDKAL1 GENEPOLYMORPHISMRS4712527DIABETIC RETINOPATHYTYPE 2 DIABETEShttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Purpose: Diabetic retinopathy (DR) is one of the chronic retinal disorders linked to diabetes and remains the leading cause of blindness in working-age people. Many studies have demonstrated the existence of associations between type 2 diabetes mellitus (T2DM) and variants in the cyclin-dependent kinase 5 regulatory subunit?associated protein 1-like 1 (CDKAL1) gene. Here, weperformed a case-control study in the CDKAL1 gene (rs4712527 polymorphism) to investigate the potential association between this single-nucleotide polymorphism (SNP) and DR risk. Methods: Two hundred thirty-one patients with T2DM (126 patients with proliferative diabetic retinopathy [PDR] and 105 patients without diabetic retinopathy [WDR]), who assisted at the CentroPrivado de Ojos Romagosa, Fundacio´n VER, were studied. An independent cohort of 98 patients (56 with PDR and 42 with WDR) from the Hospital Nacional de Clı´nicas was taken for replication. A complete ophthalmological examination included an externalexamination of the eye and adnexa, pupil responsiveness, and slit-lamp biomicroscopic examination. Genotyping of rs4712527 was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The odds ratio (OR) and 95% CI were calculated by unconditional logistic regression adjusted for diabetes duration, body mass index, insulin therapy,HbA1c, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure. Results: Analysis from the rs4712527 SNP in the Centro Privado de Ojos Romagosa, Fundacio´n VER, cohort was found to be associated with decreased risk of PDR both before and after adjustment, under the codominant (adjustedOR ¼ 0.16 [95% CI, 0.06-0.44]; P ¼ 4e-04), dominant (adjusted OR ¼ 0.17 [95% CI, 0.07-0.43]; P ¼ 1e-04), overdominant (adjusted OR ¼ 0.20 [95% CI, 0.08-0.52]; P ¼ 5e-04), and log-additive (adjusted OR ¼ 0.28 [95% CI, 0.13-0.59]; P ¼ 4e-04)models. In the combined analysis including both cohorts, the rs4712527 was nominally involved as a protective factor in the development of DR. Conclusions: Our findings suggest that the rs4712527 in the CDKAL1 gene might be involved in the protection to develop PDR in T2DM.Fil: Yang, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; ArgentinaFil: Luna, José Domingo. Fundaciòn Ver; ArgentinaFil: Alcoba, Emilio. Fundaciòn Ver; ArgentinaFil: Sein, Aylén. Fundaciòn Ver; ArgentinaFil: Gramajo, Ana Laura. Fundaciòn Ver; ArgentinaFil: Juárez, Claudio P.. Fundaciòn Ver; ArgentinaFil: Beltramo, Dante Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Provincia de Córdoba. Ministerio de Ciencia y Técnica. Centro de Excelencia en Productos y Procesos de Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; ArgentinaFil: Soria, Néstor Walter. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; ArgentinaSAGE Publications2018-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/164341Yang, Pablo; Luna, José Domingo; Alcoba, Emilio; Sein, Aylén; Gramajo, Ana Laura; et al.; The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes; SAGE Publications; Journal of VitreoRetinal Diseases; 2; 4; 5-2018; 1-82474-12642474-1272CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/2474126418777405info:eu-repo/semantics/altIdentifier/doi/10.1177/2474126418777405info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-11-12T09:41:53Zoai:ri.conicet.gov.ar:11336/164341instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-11-12 09:41:53.57CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes |
| title |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes |
| spellingShingle |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes Yang, Pablo CDKAL1 GENE POLYMORPHISM RS4712527 DIABETIC RETINOPATHY TYPE 2 DIABETES |
| title_short |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes |
| title_full |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes |
| title_fullStr |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes |
| title_full_unstemmed |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes |
| title_sort |
The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes |
| dc.creator.none.fl_str_mv |
Yang, Pablo Luna, José Domingo Alcoba, Emilio Sein, Aylén Gramajo, Ana Laura Juárez, Claudio P. Beltramo, Dante Miguel Soria, Néstor Walter |
| author |
Yang, Pablo |
| author_facet |
Yang, Pablo Luna, José Domingo Alcoba, Emilio Sein, Aylén Gramajo, Ana Laura Juárez, Claudio P. Beltramo, Dante Miguel Soria, Néstor Walter |
| author_role |
author |
| author2 |
Luna, José Domingo Alcoba, Emilio Sein, Aylén Gramajo, Ana Laura Juárez, Claudio P. Beltramo, Dante Miguel Soria, Néstor Walter |
| author2_role |
author author author author author author author |
| dc.subject.none.fl_str_mv |
CDKAL1 GENE POLYMORPHISM RS4712527 DIABETIC RETINOPATHY TYPE 2 DIABETES |
| topic |
CDKAL1 GENE POLYMORPHISM RS4712527 DIABETIC RETINOPATHY TYPE 2 DIABETES |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Purpose: Diabetic retinopathy (DR) is one of the chronic retinal disorders linked to diabetes and remains the leading cause of blindness in working-age people. Many studies have demonstrated the existence of associations between type 2 diabetes mellitus (T2DM) and variants in the cyclin-dependent kinase 5 regulatory subunit?associated protein 1-like 1 (CDKAL1) gene. Here, weperformed a case-control study in the CDKAL1 gene (rs4712527 polymorphism) to investigate the potential association between this single-nucleotide polymorphism (SNP) and DR risk. Methods: Two hundred thirty-one patients with T2DM (126 patients with proliferative diabetic retinopathy [PDR] and 105 patients without diabetic retinopathy [WDR]), who assisted at the CentroPrivado de Ojos Romagosa, Fundacio´n VER, were studied. An independent cohort of 98 patients (56 with PDR and 42 with WDR) from the Hospital Nacional de Clı´nicas was taken for replication. A complete ophthalmological examination included an externalexamination of the eye and adnexa, pupil responsiveness, and slit-lamp biomicroscopic examination. Genotyping of rs4712527 was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The odds ratio (OR) and 95% CI were calculated by unconditional logistic regression adjusted for diabetes duration, body mass index, insulin therapy,HbA1c, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure. Results: Analysis from the rs4712527 SNP in the Centro Privado de Ojos Romagosa, Fundacio´n VER, cohort was found to be associated with decreased risk of PDR both before and after adjustment, under the codominant (adjustedOR ¼ 0.16 [95% CI, 0.06-0.44]; P ¼ 4e-04), dominant (adjusted OR ¼ 0.17 [95% CI, 0.07-0.43]; P ¼ 1e-04), overdominant (adjusted OR ¼ 0.20 [95% CI, 0.08-0.52]; P ¼ 5e-04), and log-additive (adjusted OR ¼ 0.28 [95% CI, 0.13-0.59]; P ¼ 4e-04)models. In the combined analysis including both cohorts, the rs4712527 was nominally involved as a protective factor in the development of DR. Conclusions: Our findings suggest that the rs4712527 in the CDKAL1 gene might be involved in the protection to develop PDR in T2DM. Fil: Yang, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina Fil: Luna, José Domingo. Fundaciòn Ver; Argentina Fil: Alcoba, Emilio. Fundaciòn Ver; Argentina Fil: Sein, Aylén. Fundaciòn Ver; Argentina Fil: Gramajo, Ana Laura. Fundaciòn Ver; Argentina Fil: Juárez, Claudio P.. Fundaciòn Ver; Argentina Fil: Beltramo, Dante Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Provincia de Córdoba. Ministerio de Ciencia y Técnica. Centro de Excelencia en Productos y Procesos de Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina Fil: Soria, Néstor Walter. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina |
| description |
Purpose: Diabetic retinopathy (DR) is one of the chronic retinal disorders linked to diabetes and remains the leading cause of blindness in working-age people. Many studies have demonstrated the existence of associations between type 2 diabetes mellitus (T2DM) and variants in the cyclin-dependent kinase 5 regulatory subunit?associated protein 1-like 1 (CDKAL1) gene. Here, weperformed a case-control study in the CDKAL1 gene (rs4712527 polymorphism) to investigate the potential association between this single-nucleotide polymorphism (SNP) and DR risk. Methods: Two hundred thirty-one patients with T2DM (126 patients with proliferative diabetic retinopathy [PDR] and 105 patients without diabetic retinopathy [WDR]), who assisted at the CentroPrivado de Ojos Romagosa, Fundacio´n VER, were studied. An independent cohort of 98 patients (56 with PDR and 42 with WDR) from the Hospital Nacional de Clı´nicas was taken for replication. A complete ophthalmological examination included an externalexamination of the eye and adnexa, pupil responsiveness, and slit-lamp biomicroscopic examination. Genotyping of rs4712527 was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The odds ratio (OR) and 95% CI were calculated by unconditional logistic regression adjusted for diabetes duration, body mass index, insulin therapy,HbA1c, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure. Results: Analysis from the rs4712527 SNP in the Centro Privado de Ojos Romagosa, Fundacio´n VER, cohort was found to be associated with decreased risk of PDR both before and after adjustment, under the codominant (adjustedOR ¼ 0.16 [95% CI, 0.06-0.44]; P ¼ 4e-04), dominant (adjusted OR ¼ 0.17 [95% CI, 0.07-0.43]; P ¼ 1e-04), overdominant (adjusted OR ¼ 0.20 [95% CI, 0.08-0.52]; P ¼ 5e-04), and log-additive (adjusted OR ¼ 0.28 [95% CI, 0.13-0.59]; P ¼ 4e-04)models. In the combined analysis including both cohorts, the rs4712527 was nominally involved as a protective factor in the development of DR. Conclusions: Our findings suggest that the rs4712527 in the CDKAL1 gene might be involved in the protection to develop PDR in T2DM. |
| publishDate |
2018 |
| dc.date.none.fl_str_mv |
2018-05 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/164341 Yang, Pablo; Luna, José Domingo; Alcoba, Emilio; Sein, Aylén; Gramajo, Ana Laura; et al.; The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes; SAGE Publications; Journal of VitreoRetinal Diseases; 2; 4; 5-2018; 1-8 2474-1264 2474-1272 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/164341 |
| identifier_str_mv |
Yang, Pablo; Luna, José Domingo; Alcoba, Emilio; Sein, Aylén; Gramajo, Ana Laura; et al.; The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes; SAGE Publications; Journal of VitreoRetinal Diseases; 2; 4; 5-2018; 1-8 2474-1264 2474-1272 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/2474126418777405 info:eu-repo/semantics/altIdentifier/doi/10.1177/2474126418777405 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
SAGE Publications |
| publisher.none.fl_str_mv |
SAGE Publications |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1848597605308694528 |
| score |
13.142177 |